Cas:1233-53-0 (2E)-2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methylidene]butanoic acid manufacturer & supplier

We serve Chemical Name:(2E)-2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methylidene]butanoic acid CAS:1233-53-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2E)-2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methylidene]butanoic acid

Chemical Name:(2E)-2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methylidene]butanoic acid
CAS.NO:1233-53-0
Synonyms:Bunamiodilo;Bunamiodylum;Bunamijodylum;BUNAMIODYL;Bunamiodylsaeure;3-(3-Butylamido-2,4,6-triiodphenyl)-2-ethylacrylsaeure;2-(3-Butyramido-3,4,6-triiodophenylmethylene)butyric acid;Buniodyl;Bunamiodylum [INN-Latin];2-(3-Butyrylamino-2,4,6-triiod-benzyliden)-buttersaeure;Bunamiodilo [INN-Spanish]
Molecular Formula:C15H16I3NO3
Molecular Weight:639.00600
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:623ºC at 760mmHg
Density:2.202g/cm3
Index of Refraction:1.723
PSA:69.89000
Exact Mass:638.82600
LogP:5.76650

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Bunamiodilo chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bunamiodilo [INN-Spanish] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bunamiodilo Use and application,2-(3-Butyramido-3,4,6-triiodophenylmethylene)butyric acid technical grade,usp/ep/jp grade.


Related News: In the US, however, ODAC in April voted to keep alive the accelerated approval for Tecentriq plus Abraxane (nab-paclitaxel) in mTNBC while additional confirmatory trials are ongoing. [(1R,3S,4R)-3-Hydroxy-4,7,7-trimethylbicyclo[2.2.1]hept-2-yl]acet ic acid manufacturers “With our commercial capability, we will definitely make sure that we can stabilize and continue growing,” Wang said. 1-(1,3-benzodioxol-5-yl)-N-methylmethanamine,hydrochloride suppliers The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. (3-tert-butylphenyl) N-methylcarbamate vendor & factory.